Objective To provide recommendations on prevention, screening, genetics, treatment and management of people at risk of hereditary CRC colorectal cancer syndromes. The American Society of Clinical Oncology ASCO has a policy and set of procedures to approve clinical practice guidelines that have been developed by, CLINICAL PRACTICE GUIDELINE Clinical Practice Guideline on Screening for Colorectal Cancer in Individuals With an Family History of Nonhereditary Colorectal Cancer or Adenoma: The Canadian Association of Gastroenterology Banff Consensus Desmond Leddin,1,2, David A. Lieberman,3, Frances Tse, N. Barkun,5UL TR NCATS NIH HHS United States. The NCCN Guidelines for CRC Screening for Colorectal Cancer describe various colorectal screening modalities as well as recommended screening programs for patients at average or increased risk of developing sporadic CRC. They are intended to help doctors with clinical decision making, inclusion and exclusion criteria. CPGs were reviewed by two separate reviewers based on eligibility criteria. Inclusion criteria were as follows: 1 guideline published in English or Chinese, 2 guidelines, consensus or position statements originally published regarding nutrition in patients with colorectal cancer, abstract. This selection of NCCN clinical practice guidelines in oncology NCCN guidelines for colon cancer focuses on systemic therapeutic options for the treatment of metastatic colorectal mCRC, as significant updates have recently been made to this section. These updates include recommendations for first line, adapted from: Peterse EFP, Meester RGS, Siegal RL, et al. The impact of increasing incidence of colorectal cancer in young adults on the optimal age to initiate screening: microsimulation analysis I to inform the American Cancer Society colorectal cancer screening guidelines. Cancer. 10.1002 cncr.31543 epub ahead of print. 34Subsequently, they could use this predicted colorectal cancer risk to search for the best MISCAN-Colon predictions of risk-matched screening results, to obtain a personal estimate of the magnitude of the benefits and harms of colorectal cancer screening . The clinical practice guideline provides relevant details.15